Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 2 | 0 | 0 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
thioredoxin reductase | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 2 | 0 | 0 | 2 |
NFKB1 protein, partial | 1 | 0 | 0 | 1 |
GLS protein | 2 | 0 | 0 | 2 |
thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
alpha-galactosidase | 1 | 0 | 0 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 4 | 0 | 0 | 4 |
cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
chromobox protein homolog 1 | 2 | 0 | 0 | 2 |
flap endonuclease 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 1 | 0 | 0 | 1 |
muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Cytochrome P450 3A4 | 0 | 0 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain B, Protein (streptavidin) | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain D, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin Complex With Biotin | 0 | 0 | 1 | 1 |
Chain D, Circularly Permuted Core-streptavidin E51/a46 | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain D, Core-streptavidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, Streptavidin | 0 | 0 | 1 | 1 |
Chain B, Streptavidin | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
RAR-related orphan receptor gamma | 3 | 0 | 0 | 3 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
estrogen nuclear receptor alpha | 5 | 0 | 0 | 5 |
green fluorescent protein, partial | 0 | 1 | 0 | 1 |
vitamin D3 receptor isoform VDRA | 3 | 0 | 0 | 3 |
insulin-degrading enzyme isoform 1 | 0 | 0 | 1 | 1 |
Streptavidin | 0 | 0 | 1 | 1 |
Receptor-type tyrosine-protein phosphatase beta | 0 | 0 | 0 | 1 |
Chain A, HADH2 protein | 1 | 0 | 0 | 1 |
Chain B, HADH2 protein | 1 | 0 | 0 | 1 |
Chain A, Ferritin light chain | 1 | 0 | 0 | 1 |
Chain A, Cruzipain | 1 | 0 | 0 | 1 |
Luciferase | 1 | 0 | 0 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
USP1 protein, partial | 3 | 0 | 0 | 3 |
Microtubule-associated protein tau | 1 | 0 | 0 | 1 |
AR protein | 3 | 0 | 0 | 3 |
aldehyde dehydrogenase 1 family, member A1 | 2 | 0 | 0 | 2 |
glucocorticoid receptor [Homo sapiens] | 3 | 0 | 0 | 3 |
retinoid X nuclear receptor alpha | 2 | 0 | 0 | 2 |
farnesoid X nuclear receptor | 3 | 0 | 0 | 3 |
pregnane X nuclear receptor | 4 | 0 | 0 | 4 |
peroxisome proliferator-activated receptor delta | 2 | 0 | 0 | 2 |
peroxisome proliferator activated receptor gamma | 3 | 0 | 0 | 3 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 2 | 0 | 0 | 2 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 3 | 0 | 0 | 3 |
nuclear receptor ROR-gamma isoform 1 | 1 | 0 | 0 | 1 |
geminin | 5 | 0 | 0 | 5 |
DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 1 | 0 | 1 | 2 |
Cellular tumor antigen p53 | 4 | 0 | 0 | 4 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 1 | 0 | 1 | 2 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 1 | 0 | 1 | 2 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
Nuclear receptor ROR-gamma | 1 | 0 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 1 | 0 | 1 | 2 |
Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
60 kDa chaperonin | 0 | 1 | 0 | 1 |
10 kDa chaperonin | 0 | 1 | 0 | 1 |
GABA theta subunit | 1 | 0 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 1 | 0 | 1 | 2 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
General amino-acid permease GAP1 | 0 | 0 | 0 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
arylsulfatase A | 1 | 0 | 0 | 1 |
Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 0 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Asc-type amino acid transporter 1 | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
TDP1 protein | 3 | 0 | 0 | 3 |
EWS/FLI fusion protein | 1 | 0 | 0 | 1 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Histone H2A.x | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
lamin isoform A-delta10 | 3 | 0 | 0 | 3 |
ATP-binding cassette sub-family C member 3 | 0 | 2 | 0 | 2 |
Multidrug resistance-associated protein 4 | 0 | 2 | 0 | 2 |
Flavodoxin | 0 | 0 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 2 | 0 | 2 |
cytochrome P450 2D6 | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
peripheral myelin protein 22 | 2 | 0 | 0 | 2 |
histone acetyltransferase KAT2A isoform 1 | 1 | 0 | 0 | 1 |
Inositol monophosphatase 1 | 1 | 0 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Chain A, Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
glp-1 receptor, partial | 2 | 0 | 0 | 2 |
pregnane X receptor | 1 | 0 | 0 | 1 |
SMAD family member 2 | 1 | 0 | 0 | 1 |
SMAD family member 3 | 1 | 0 | 0 | 1 |
GLI family zinc finger 3 | 1 | 0 | 0 | 1 |
Smad3 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 1 | 0 | 0 | 1 |
nuclear receptor subfamily 1, group I, member 3 | 1 | 0 | 0 | 1 |
progesterone receptor | 2 | 0 | 0 | 2 |
retinoic acid nuclear receptor alpha variant 1 | 1 | 0 | 0 | 1 |
estrogen-related nuclear receptor alpha | 2 | 0 | 0 | 2 |
67.9K protein | 1 | 0 | 0 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 2 | 0 | 0 | 2 |
activating transcription factor 6 | 1 | 0 | 0 | 1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
thyroid hormone receptor beta isoform 2 | 2 | 0 | 0 | 2 |
Vpr | 1 | 0 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 1 | 0 | 0 | 1 |
Estrogen receptor | 0 | 2 | 1 | 3 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Progesterone receptor | 0 | 2 | 1 | 3 |
Glycine receptor subunit alpha-1 | 0 | 2 | 0 | 2 |
ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
Mineralocorticoid receptor | 0 | 2 | 0 | 3 |
Androgen receptor | 0 | 3 | 1 | 4 |
Androgen receptor | 0 | 2 | 0 | 3 |
Glutamate receptor 2 | 1 | 0 | 0 | 1 |
Glycine receptor subunit beta | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-2 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-3 | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Spike glycoprotein | 1 | 0 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 1 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 1 | 0 | 0 | 1 |
Ataxin-2 | 1 | 0 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 1 | 0 | 0 | 1 |
glucocerebrosidase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 1 | 0 | 2 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prothrombin | 0 | 0 | 1 | 1 |
Transthyretin | 0 | 0 | 0 | 1 |
Thyroid hormone receptor alpha | 0 | 2 | 2 | 4 |
Thyroid hormone receptor beta | 0 | 2 | 2 | 4 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Solute carrier organic anion transporter family member 1A2 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B1 | 0 | 0 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |